Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.016
Sell
RSI(14)
33.720
Neutral
STOCH(KDJ)(9,3,3)
15.407
Oversold
ATR(14)
0.151
High Vlolatility
CCI(14)
-111.684
Sell
Williams %R
82.090
Oversold
TRIX(12,20)
-1.295
Sell
StochRSI(14)
79.725
Buy
Search
iSpecimen Inc
ISPCAdd to Watchlist
1.880USD
+0.050+2.73%
Close 07-31 16:00（ET）Quotes delayed by 15 min
34.85KMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+2.73%
5 Days
-4.57%
1 Month
-31.14%
6 Months
+435.46%
Year to Date
+622.80%
1 Year
+51.61%
Key Figures
1.890Open
1.900High
35.79KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
193.07%Turnover Ratio
1.830Prev. Close
1.770Low
38.40KTurnover
LossP/E Static
0.04P/B
0.00%Div Yield TTM
-165.08%ROA
127.20052wk High
0.84Volume Ratio
-12.50MNet Profit
18.54KShares
-329.1860EPS TTM
1.66Beta
-894.59%ROE
3.11052wk Low
7.10%Amplitude
45.89%Gross Margin
34.85KMarket Cap
-2.08Reward/Risk
14.76%Risk Rate
TradingKey Stock Score of iSpecimen Inc
Currency: USD Updated: 2026-07-30Key Insights
iSpecimen Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 220 out of 486 in the Software & IT Services industry.Institutional ownership is low.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
iSpecimen Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
iSpecimen Inc Highlights
StrengthsRisks
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.93M.
Overvalued
The company’s latest PE is -0.01, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.11K shares, decreasing 93.98% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
iSpecimen Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.904
Sell
MA10
2.055
Sell
MA20
2.206
Sell
MA50
2.636
Sell
MA100
3.385
Sell
MA200
1.919
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
iSpecimen Inc Info
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Ticker SymbolISPC
CompanyiSpecimen Inc
CEOField (Katharyn)
Websitehttps://www.ispecimen.com/
Shareholders
Related Instruments
-4.39%
+6.90%
+6.75%
+3.08%
+3.28%
-0.03%
-0.69%
+1.80%
-2.02%
+0.64%
+5.15%
+1.89%
+1.56%
+0.92%
+3.04%
+1.86%
-0.00%
-1.98%
+1.28%
+5.00%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of iSpecimen Inc (ISPC)?
The current price of iSpecimen Inc (ISPC) is 1.88.
What is the symbol of iSpecimen Inc?
The ticker symbol of iSpecimen Inc is ISPC.
What is the 52-week high of iSpecimen Inc?
The 52-week high of iSpecimen Inc is 127.20.
What is the 52-week low of iSpecimen Inc?
The 52-week low of iSpecimen Inc is 3.11.
What is the market capitalization of iSpecimen Inc?
The market capitalization of iSpecimen Inc is 34.85K.
What is the Earnings Per Share (EPS TTM) of iSpecimen Inc (ISPC)?
The Earnings Per Share (EPS TTM) of iSpecimen Inc (ISPC) is -91.15.